Yes, but the prerequisite is that silibinin powder must be high-purity (≥ 95%), stable crystal form (A/B equimolar mixture), validated by HPLC, and meet pharmaceutical/high activity research grade standards, rather than the vague "silymarin" mixture found in ordinary plant extracts.
Silibinin, CAS number 22888-70-6, is the most biologically active flavonoid lignan monomer in Silybum marianum seeds, accounting for 65-80% of the total active ingredients in standardized Silymarin extracts. It is not a conceptual health product ingredient, but a natural small molecule compound with a clear chemical structure, quantifiable pharmacological mechanism, and preclinical and partially clinically validated data. Since its first isolation by German scientists in 1968, its four major mechanisms of liver cell membrane stability, antioxidant, anti-inflammatory, and anti fibrotic properties have been repeatedly confirmed. However, a large number of products labeled as "silymarin" on the market are actually low purity silymarin crude extracts, with unknown active ingredient content, complex impurity spectra, and poor stability - this is the root cause of the industry's trust crisis.
🧪 Background: Why does "protecting the liver" often become a marketing tactic? The truth lies at the molecular level
Traditional "liver protection" promotion often talks in general terms, lacking targets and dosage basis. The scientific validity of silibinin is precisely reflected in its verifiable molecular pathways of action:
Direct free radical scavenging: Its phenolic hydroxyl structure efficiently neutralizes ROS (reactive oxygen species) and protects the mitochondrial membrane potential of liver cells;
Enhancing endogenous antioxidant system: significantly upregulating the expression of glutathione (GSH) and superoxide dismutase (SOD), enhancing the liver's ability to self detoxify;
Cell membrane stabilization: Embedding into the phospholipid bilayer of liver cell membrane, physically blocking the transmembrane invasion of toxins such as α - Amanitin, which is the key to its specific rescue value for mushroom poisoning;
Regulating signaling pathways: inhibiting NF - κ B activation, downregulating pro-inflammatory factors such as TNF - α and IL-6; Simultaneously activate the Nrf2 pathway and drive the expression of protective proteins such as HO-1.
These mechanisms are not theoretical speculations and have been cross validated by HPLC-MS, Western blot, and histopathological methods in human primary liver cells, HepG2 cell lines, and rat CCl ₄ liver injury models. The real silibinin powder should be the material carrier of this series of precise biological effects, rather than the vague "plant essence".
📊 Core dimension comparison: Choosing the right silibinin powder depends on these 5 hard indicators
| dimension | Dimension high-quality silibinin powder (scientific/pharmaceutical grade) |
Ordinary "Silymarin" products | key differences |
| Purity and Certification | ≥95% HPLC-DAD/ELSD validation); Containing a clear A/B isomer ratio (≈ 1:1) | The nominal "80% silymarin" has not been tested for actual silibinin content and often contains unknown impurities | Purity determines bioavailability and experimental reproducibility; A/B isomers synergistically enhance efficiency, while the activity of a single isomer is significantly reduced |
| Solubility and stability | Soluble in DMSO (≥ 5 mg/mL); Powder stored at 2-8 ℃ in the dark for 2 years, stable | Poor water solubility, often adding unknown solvents; Easy to oxidize and discolor under high temperature/light exposure | Solubility affects the concentration accuracy of in vitro experiments; Stability guarantee, long-term storage effectiveness |
| Application verification | Clearly support liver protection, anti-cancer (prostate/breast/lung cancer cell lines), and anti ovarian toxicity (pig oocyte model) | The functional claims are vague and lack specific cell/animal model data support | Application scenarios need to match real research evidence to avoid "universal labels" |
| compliance | Complies with USP/EP pharmacopoeia standards; Non sterile but filterable (0.22 μ m organic filter membrane) without a clear pharmacopoeia compliance statement; | Some products exceed the microbial limit (self inspection required) | Compliance is the entry threshold for drug development or high-end health products |
| Supply chain transparency | Provide COA (Certificate of Analysis), HPLC chromatogram, and heavy metal/solvent residue report | COA is missing or only contains simple content statements, with no trace of the spectrum |
Transparency is a direct reflection of q uality controllability |
Additional explanation: The low oral bioavailability (<50%) of silibinin powder is a bottleneck for its clinical translation, so cutting-edge research is focusing on nano delivery systems (such as PCL/Pluronic F68 nanoparticles) to improve lung targeting and liver accumulation efficiency. When selecting raw materials for formulation development, their compatibility with carrier materials needs to be evaluated simultaneously.
🌟Research progress on the efficacy of silibinin powder
✅In terms of anti-cancer: Numerous studies have shown that silibinin powder has anti-cancer and chemopreventive effects, and can inhibit cell proliferation and migration. In vitro experiments, it showed anti-cancer effects on human prostate cancer cells, estrogen dependent/independent human breast cancer cells, human colon cancer cells and other cancer cells. However, its accurate biochemical anti-cancer mechanism is still under study, which may be related to its effects on cell proliferation, apoptosis, inflammation, angiogenesis, and metabolism.
✅In terms of liver protection: Studies have shown that silibinin powder can protect liver cells from toxin damage and has a hepatoprotective effect. In animal experiments, silibinin can provide certain protective and reparative effects against liver damage caused by toxins.
✅Other aspects: In the study of treating Alzheimer's disease, a nanostructured lipid carrier loaded with Silibinin was developed for the treatment of Alzheimer's disease induced by amyloid beta in Wistar rats. The results showed that in oral administration systems, this formulation can be considered a promising option for treating Alzheimer's disease
✅Research status and prospects: There have been many achievements in the study of the efficacy of Silibinin powder, but there are still many unknown areas waiting to be explored. For example, its anti-cancer mechanism still needs further research to clarify, and its potential in the treatment of other diseases also needs to be further explored. In the future, with the advancement and deepening of research technology, it is believed that it can play a role in the treatment of more diseases.
🌐 Application scenario: From laboratory to health consumption, its role is evolving
Research field: As a classic positive control for liver protection, used for evaluating drug-induced liver injury (DILI) models; It is also a hot topic in tumor pharmacology research - by inhibiting the STAT3 and Akt/mTOR pathways, it significantly inhibits the proliferation and migration of various cancer cells. HY-13748 (99.92% purity) provided by suppliers such as MCE and Solarbio has been widely used in cell models such as U87 glioma and A549 lung cancer.
High end health products: Different from ordinary liver protection tablets, high-purity silibinin powder can be made into sublingual instant tablets and liposome soft capsules, bypassing the first pass effect and increasing the targeted concentration of liver tissue. The EU EFSA has accepted its health claim application for "maintaining normal liver function" (based on evidence of a daily dose of 210 mg).
Functional foods and cosmetics: Their strong antioxidant properties make them potential ingredients for anti glycation (AGEs inhibition) and anti blue light damage. Previous studies have loaded it onto hyaluronic acid coated quantum dots to achieve targeted imaging of CD44 ⁺ cancer cells, confirming its biocompatibility and modification feasibility.
⚙️ Selection guide: Avoid 3 major traps and lock in the truly effective silibinin powder
Trap 1: Confusion between Silibinin and Silymarin
Silymarin is a mixture (containing silibinin, isosilibinin, silychristin, etc.), while silibinin is a single highly active component. Identify CAS 22888-70-6 and the "Silibinin (Mixture A&B)" label, and reject vague statements that only label "Silymarin Extract".
Trap 2: Neglecting storage and dissolution requirements
The powder needs to be stored at 2-8 ℃ away from light; The mother liquor must be prepared using DMSO (non ethanol/water) and stored separately at -20 ℃ for ≤ 1 month. Immediately use after dissolving at room temperature to avoid degradation caused by repeated freeze-thaw cycles.
Trap Three: Believing in 'Nature is Safe'
Even with natural ingredients, high doses still require safety assessment. The literature records that the intravenous LD of mice is 1056 mg/kg30, but the safety window for long-term oral administration needs to be determined based on the specific formula. It is necessary to verify whether the supplier provides GLP toxicology reports (especially for human testing).
📌Conclusion
With the improvement of people's health awareness and the increasing attention to liver health, the demand for silibinin related products will continue to grow. In addition, the acceptance of health products and natural medicines in some emerging markets is constantly increasing, providing new growth space for the market of Silymarin powder. Researchers continue to study the pharmacological effects of silibinin, constantly discovering new efficacy and application areas, which will further expand the market prospects of silibinin powder. The market for Silymarin powder has attracted the participation of many enterprises, and the market competition is relatively fierce. Some small businesses may compete for market share by lowering prices, which may affect the pricing system and profit margins of the entire market. The quality of Silymarin powder products on the market varies greatly, and some products may have issues such as low purity and high impurities, which may affect consumers' trust in the product.
Overall, the market outlook for Silibinin powder is optimistic, but companies need to address challenges such as market competition and product quality. By improving product quality, strengthening research and development, and market promotion, they can enhance their competitiveness and achieve better development in the market.
Xi'an Faithful BioTech Co., Ltd provide you with the highest quality silibinin powder CAS 22888-70-6 with a purity of 99%,Send your Inquiry for more details, Click email：sales2@faithfulbio.com Now.
🔍reference
1. Overview of Contact Lens Materials: A Materials Science Perspective [2606-03-06]
2. Silibinin Silibinin Inhibitors, Antagonists, and Agonists
3. Healthcare supplement ingredients silymarin powder milk thistle p.e. By Xian ...[2026-01-19]
4. Lung cancer targeting efficiency of Silibinin loaded Poly Caprolactone /...[2022-05-13]
5. Silibinin Silibinin 22888-70-6 brand [2024 December 31]
6. HERBASEA Natural Milk Thistle Extract Powder Silybum Marianum Extract ...[2024-12-23]
7. Silibinin Silibinin_
8. China Silibinin Powder Manufacturers Suppliers Factory[2023-11-07]
9. Natural silibinin modulates amyloid precursor protein processing and amyloid...[2019-07-01]
10. Analysis Report on the Market Size, Segmented Share Proportion, and Future Development Direction of Xiaoer Qingfei Powder in China [August 8, 2023]
11. Neutron-enhanced ion transport in cathode coating of Li-ion batteries[2026-03-13]
12. Aldehyde ketone reductase metabolizes glyphosate and confers resistance to barnyard grass [2026-02-23]
13. Emergent Loewner Dynamics in Slime Mold Growth[2026-03-10]